摘要
<strong>Introduction:</strong> The exhaustion of healthcare resources due to the rising prevalence in Saudi Arabia mandates the search for each method that can help in better control of diabetes. <strong>Methods:</strong> The gathered task force gath-ered to develop an explicit, evidence-based consensus for the use of time-in-range targets as guidance for better glycemic control while using continuous glucose monitoring (CGM). This article has the recommenda-tions of this expert panel.<strong> Results: </strong>HbA1c and self-monitoring blood glu-cose (SMBG) are not enough to detect blood glucose (BG) fluctuations on a daily basis. The incorporation of technology like FreeStyle Libre with its applications like Libre View is now used in many institutes in Saudi Ara-bia. This system is comprehensive and has all the standardized metrics needed. However, training and support are always needed. Barriers and challenges include the awareness & experience of the technology, the time barrier, the patients’ barriers, the technical barriers, and of course, the availability barrier. All the barriers and challenges should be dealt with by designing new training programs.<strong> Conclusion:</strong> The expert panel recom-mended using CGMs technology in people with type 1 diabetes (T1DM) children and adults, type 2 diabetes (T2DM) on multiple insulin injections, gestational diabetes (GDM) who need further glycemic control, and those at high risk for hypoglycemia. In addition, we recommend using them for a short period for those who require intensive BG control or during acute illness or stress. In addition, Ambulatory Glucose Profile (AGP) could be used as an educational tool for any individuals with DM to study the im-pact of certain elements of lifestyle modifications on their immediate BG level.
<strong>Introduction:</strong> The exhaustion of healthcare resources due to the rising prevalence in Saudi Arabia mandates the search for each method that can help in better control of diabetes. <strong>Methods:</strong> The gathered task force gath-ered to develop an explicit, evidence-based consensus for the use of time-in-range targets as guidance for better glycemic control while using continuous glucose monitoring (CGM). This article has the recommenda-tions of this expert panel.<strong> Results: </strong>HbA1c and self-monitoring blood glu-cose (SMBG) are not enough to detect blood glucose (BG) fluctuations on a daily basis. The incorporation of technology like FreeStyle Libre with its applications like Libre View is now used in many institutes in Saudi Ara-bia. This system is comprehensive and has all the standardized metrics needed. However, training and support are always needed. Barriers and challenges include the awareness & experience of the technology, the time barrier, the patients’ barriers, the technical barriers, and of course, the availability barrier. All the barriers and challenges should be dealt with by designing new training programs.<strong> Conclusion:</strong> The expert panel recom-mended using CGMs technology in people with type 1 diabetes (T1DM) children and adults, type 2 diabetes (T2DM) on multiple insulin injections, gestational diabetes (GDM) who need further glycemic control, and those at high risk for hypoglycemia. In addition, we recommend using them for a short period for those who require intensive BG control or during acute illness or stress. In addition, Ambulatory Glucose Profile (AGP) could be used as an educational tool for any individuals with DM to study the im-pact of certain elements of lifestyle modifications on their immediate BG level.
作者
Saud Al Sifri
Adnan Alshaikh
Bassam Bin-Abbas
Eman Sheshah
Fahad Al Sabaan
Mohammed Al-Dawish
Mohammed Al-Dubayee
Naweed Al-Zaman
Raed A. Al-Dahash
Saad Alzahrani
Emad R. Issak
Saud Al Sifri;Adnan Alshaikh;Bassam Bin-Abbas;Eman Sheshah;Fahad Al Sabaan;Mohammed Al-Dawish;Mohammed Al-Dubayee;Naweed Al-Zaman;Raed A. Al-Dahash;Saad Alzahrani;Emad R. Issak(Endocrinology and Diabetes Department, Alhada and Taif Armed Forces Hospitals, Taif, Saudi Arabia;Pediatrics Department, King Abdulaziz Medical City—Ministry of National Guard Health Affairs, King Khalid National Guard Hospital, Jeddah, Saudi Arabia;Pediatrics Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia;Endocrinology Department, King Salman hospital, Riyadh, Saudi Arabia;Endocrinology Department, Security forces hospital program, Riyadh, Saudi Arabia;Endocrinology Department, Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia;Pediatrics Department, Ministry of National Guard Health Affairs-Riyadh, Riyadh, Saudi Arabia;Endocrinology Department, Taibah University, Madina, Saudi Arabia;Internal Medicine Department, King Abdulaziz Medical City—National Guard, Riyadh, Saudi Arabia;Endocrinology Department, Medical Director, OEMC, King Fahad Medical City, Riyadh, Saudi Arabia;Internal Medicine Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt)
